From KenSci Gets $22M for Tools to Help Hospitals Flag High-Risk Patients:

KenSci co-founder and CEO Samir Manjure—

Seattle-based KenSci develops software designed to help healthcare organizations predict which of their patients are most likely to get sick. Image courtesy of KenSci.

Underwriters and Partners

Xconomy Insight

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

From Our Editors · Special Report
2019 Biopharma Outlook – Facing an Uncertain Future
Key indicators & expert insight from industry leaders
Xconomy

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy Boston

New Meds Set to Reshape US CNS and oncology Markets

FDA Clinical Hold Stops LogicBio’s Gene Editing Study Before It Starts

BioIntelliSense Debuts "Sticker” Sensor to Capture Patient Data Remotely

Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal

Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira

Agile Therapeutics Wins FDA Nod for Twirla Contraceptive Patch

Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%

Ligand’s Icagen Deal Brings Neuro, CF Assets Plus Partnering Potential

Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer

A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns

Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing

AI Can Unlock Health Data's Potential, But Access Is Still Difficult

After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune

Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits

Xcelerating Life Sciences San Diego

Xcelerating Life Sciences Philadelphia

Xcelerating Life Sciences San Francisco

From KenSci Gets $22M for Tools to Help Hospitals Flag High-Risk Patients:

Underwriters and Partners

How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook

2019 Biopharma Outlook – Facing an Uncertain Future

Robert Langer reveals secrets to early-stage biotech success

Xconomy on Demand

We offer a number of ways to subscribe for free!